Trials / Completed
CompletedNCT02180737
Dexmedetomidine for Sedation During Radiological Interventional Procedures
Evaluation of Role of Dexmedetomidine as a Sole Agent in Sedation of Cancer Patients Undergoing Radiological Interventional Procedures
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- National Cancer Institute, Egypt · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of the role of dexmedetomidine as a sole agent in sedating patients undergoing interventional radiological procedures and measuring its different outcome variables.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexmeditomedine |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2014-12-01
- Completion
- 2015-01-01
- First posted
- 2014-07-03
- Last updated
- 2016-04-19
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT02180737. Inclusion in this directory is not an endorsement.